A phase I study of weekly dosing of trastuzumab-DM1 (T-DM1) in patients with advanced HER2+ breast cancer

Authors
Category Primary study
JournalCancer Research
Year 2009
This article has no abstract
Epistemonikos ID: a4874f51151a7ec787a209d2fc6796518fb73dfd
First added on: Feb 28, 2025